Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call

Presentation

A Robust and Flexible Baculovirus-Insect Cell System for AAV Vector Production with Improved Yield, Capsid Ratios and Potency

Download PDF